Thomas Eklund

Director

BoardM

FI·FIN-FSA

Swedencare AB (publ)Swedencare AB (publ)Addvise AB Addvise AB ADDvise Group AB (publ)ADDvise Group AB (publ)Surgical Science Sweden AB Surgical Science Sweden AB Swedencare Swedencare

Cumul. flow

Total declarations

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Thomas Eklund, Director. Director active across 10 companies, notably Swedencare AB (publ). Aggregated, 5 filings have been logged. The latest transaction was filed on 16 February 2026 — Purchase. Regulator: FIN-FSA. All data is free.

Declarations5 total

Executives●PurchaseSSwedencare25FIN-FSA

Thomas EklundStyrelseledamot

€94,04542,918 shares@ €2.19130.0023% mcap100.0% of flow

Aktie

FI:A003W175-1·16 Feb 2026

Ideal exit: 13 Nov 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseSSurgical Science Sweden AB22FIN-FSA

Thomas EklundStyrelseledamot

€251,62085,375 shares@ €2.94720.015% mcap100.0% of flow

Aktie

FI:A003U255-1·28 Nov 2025

Ideal exit: 25 Aug 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseAADDvise Group AB (publ)7FIN-FSA

Thomas EklundStyrelseledamot

01,304,348 shares0

Aktie

FI:A003N889-1·5 May 2025

Ideal exit: 30 Jan 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseAAddvise AB7FIN-FSA

Thomas EklundStyrelseledamot

04,593,615 shares0

Teckningsoption

FI:A003N596-1·25 Apr 2025

Ideal exit: 20 Jan 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseSSwedencare AB (publ)18FIN-FSA

Thomas EklundStyrelseledamot

€38,98212,560 shares@ €3.10360.0010% mcap100.0% of flow

Aktie

FI:A003N511-1·24 Apr 2025

Ideal exit: 19 Jan 2026 (T+270)

FIN-FSA ↗

5 of 5 declarations

About Thomas Eklund

Thomas Eklund is a board member of Swedencare AB. He participates in strategic discussions and oversight of the company's operations. With his expertise, Thomas contributes to informed decision-making that supports Swedencare's mission in the healthcare sector. His commitment to excellence is an asset to the board.